RTI Surgical (“RTI” or “the Company”), a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine, announces that it has entered into an agreement to acquire Collagen Solutions, a premier global supplier of engineered medical-grade collagen and xenograft tissue with applications in cardiac, sports medicine and orthopedics. The acquisition further expands RTI’s uniquely comprehensive portfolio of allograft and xenograft biomaterials at scale, and follows the Company’s acquisition of Cook Biotech earlier in the year. RTI’s broad product portfolio enables it to partner with customers and surgeons to develop innovative solutions that are focused on improving patient outcomes.
Read the full article: RTI Surgical Announces Agreement to Acquire Collagen Solutions //
Source: https://www.globenewswire.com/news-release/2024/10/07/2958793/0/en/RTI-Surgical-Announces-Agreement-to-Acquire-Collagen-Solutions.html